Patents by Inventor Lori Ann Bacca
Lori Ann Bacca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11485940Abstract: A method of making a translucent cleaning composition is disclosed. The method includes providing a perfume; providing a hydrogen bond receiving compound; providing a hydrogen bond providing compound; combining the hydrogen bond receiving compound with the hydrogen bond providing compound to create a eutectic liquid; adding the perfume to the eutectic liquid to create a perfumed eutectic liquid; and adjusting the pH of the perfumed eutectic liquid to above 6.0.Type: GrantFiled: December 4, 2020Date of Patent: November 1, 2022Assignee: The Procter & Gamble CompanyInventors: Freddy Arthur Barnabas, Gregory Thomas Waning, Lori Ann Bacca
-
Publication number: 20220332934Abstract: Water-soluble films including a polyvinyl alcohol polymer (PVOH) and one or more eutectic solvent pairs (eutectic solvent) in predefined ratios.Type: ApplicationFiled: February 3, 2022Publication date: October 20, 2022Inventors: Freddy Arthur Barnabas, Michaela Monika Czupik, Lori Ann Bacca, Daniel Brannum
-
Publication number: 20210171866Abstract: A cleaning composition is disclosed. The cleaning composition includes a hydroxy acid, a hydrogen bond acceptor, and a surfactant. The hydroxy acid and hydrogen bond acceptor are present at a molar ratio of from about 5:1 to about 1.5:1.Type: ApplicationFiled: December 4, 2020Publication date: June 10, 2021Inventors: Freddy Arthur Barnabas, Gregory Thomas Waning, Lori Ann Bacca
-
Publication number: 20210171884Abstract: A method of making a translucent cleaning composition is disclosed. The method includes providing a perfume; providing a hydrogen bond receiving compound; providing a hydrogen bond providing compound; combining the hydrogen bond receiving compound with the hydrogen bond providing compound to create a eutectic liquid; adding the perfume to the eutectic liquid to create a perfumed eutectic liquid; and adjusting the pH of the perfumed eutectic liquid to above 6.0.Type: ApplicationFiled: December 4, 2020Publication date: June 10, 2021Inventors: Freddy Arthur Barnabas, Gregory Thomas Waning, Lori Ann Bacca
-
Patent number: 7063833Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising administering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice. The single phase dentifrice will comprise an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and an effective amount of a stannous ion.Type: GrantFiled: October 27, 2003Date of Patent: June 20, 2006Assignee: The Procter & Gamble CompanyInventors: William Michael Glandorf, Lori Ann Bacca
-
Patent number: 6821507Abstract: The present invention relates to oral compositions comprising a stannous ion source, a fluoride ion source, and a polymeric mineral surface active agent that binds stannous, said compositions providing adequate therapeutic efficacy with minimal side effects of tooth staining and astringency. The composition simultaneously provides reduction and control of supragingival calculus. The present oral care compositions may be formulated as single phase or dual phase compositions. The present invention also provides a method for effective delivery of stannous-containing compositions with minimal side effects of tooth staining or astringency and with effective tartar control by administering to a subject a stable dentifrice composition comprising a clinically effective amount of stannous fluoride and/or other stannous salts in combination with a fluoride ion source and a polymeric mineral surface active agent, preferably a phosphate- or phosphonate-containing polymer.Type: GrantFiled: January 24, 2003Date of Patent: November 23, 2004Assignee: The Procter & Gamble Co.Inventors: William M. Glandorf, Lori Ann Bacca, Donald J. White, Jr., Henk J. Busscher
-
Publication number: 20040086466Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising administering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice. The single phase dentifrice will comprise an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and an effective amount of a stannous ion.Type: ApplicationFiled: October 27, 2003Publication date: May 6, 2004Applicant: The Procter & Gamble CompanyInventors: William Michael Glandorf, Lori Ann Bacca
-
Patent number: 6667027Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising administering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice.Type: GrantFiled: October 24, 2001Date of Patent: December 23, 2003Assignee: The Procter & Gamble CompanyInventors: William Michael Glandorf, Lori Ann Bacca
-
Publication number: 20030152527Abstract: The present invention relates to oral compositions comprising a stannous ion source, a fluoride ion source, and a polymeric mineral surface active agent that binds stannous, said compositions providing adequate therapeutic efficacy with minimal side effects of tooth staining and astringency. The composition simultaneously provides reduction and control of supragingival calculus. The present oral care compositions may be formulated as single phase or dual phase compositions. The present invention also provides a method for effective delivery of stannous-containing compositions with minimal side effects of tooth staining or astringency and with effective tartar control by administering to a subject a stable dentifrice composition comprising a clinically effective amount of stannous fluoride and/or other stannous salts in combination with a fluoride ion source and a polymeric mineral surface active agent, preferably a phosphate- or phosphonate-containing polymer.Type: ApplicationFiled: January 24, 2003Publication date: August 14, 2003Applicant: The Procter & Gamble CompanyInventors: William M. Glandorf, Lori Ann Bacca, Donald J. White, Henk J. Busscher
-
Patent number: 6555094Abstract: The present invention relates to oral compositions comprising a stannous ion source, a fluoride ion source, and a polymeric mineral surface active agent that binds stannous, said compositions providing adequate therapeutic efficacy with minimal side effects of tooth staining and astringency. The composition simultaneously provides reduction and control of supragingival calculus. The present oral care compositions may be formulated as single phase or dual phase compositions. The present invention also provides a method for effective delivery of stannous-containing compositions with minimal side effects of tooth staining or astringency and with effective tartar control by administering to a subject a stable dentifrice composition comprising a clinically effective amount of stannous fluoride and/or other stannous salts in combination with a fluoride ion source and a polymeric mineral surface active agent, preferably a phosphate- or phosphonate-containing polymer.Type: GrantFiled: November 10, 2000Date of Patent: April 29, 2003Assignee: The Procter & Gamble CompanyInventors: William M. Glandorf, Lori Ann Bacca, Donald J. White, Jr., Henk J. Busscher
-
Publication number: 20020106336Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising administering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice.Type: ApplicationFiled: October 24, 2001Publication date: August 8, 2002Inventors: William Michael Glandorf, Lori Ann Bacca
-
Patent number: 6350436Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising administering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice.Type: GrantFiled: November 30, 1999Date of Patent: February 26, 2002Assignee: The Procter & Gamble CompanyInventors: William Michael Glandorf, Lori Ann Bacca
-
Patent number: 5733530Abstract: Disclosed are tartar control dentifrice compositions containing certain ranges of thymol. These compositions can also include propylene glycol and/or one or more antibacterial agents.Type: GrantFiled: August 30, 1996Date of Patent: March 31, 1998Assignee: The Procter & Gamble CompanyInventors: Lori Ann Bacca, Anthony Charles Lanzalaco